what to expect when starting retatrutide Retatrutide: From This Investigational Weight-Loss Medicine – Bolt Pharmacy This is not me telling

Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): An open-label, randomised controlled trial

Evidence-based recommendations suggest aiming for: 1.2 to 1.6 g/kg of body weight per day: This range is frequently cited as beneficial for active individuals and those aiming to preserve lean mass during calorie restriction or aging

On the second question - FeelGood specifically - FeelGood reports that patients on its GLP-1 program lose 15-20% of body weight on average

Primary Outcome: Incidence of Hearing Loss The main results of the primary outcome revealed that lixisenatide (number needed to harm = 757.75) was associated with increased events of hearing loss in comparison with the controls

doi: 10.1186/s10020023-007173 64 YeFChaiWXieMYangMYuYCaoLet al

Estrogen and GLP-1 receptor agonists both activate PI3K-Akt, which governs insulin sensitivity and cell survival, and AMPK, the cell's master energy sensor